VentriPoint Diagnostics Ltd.  

(Public, CVE:VPT)   Watch this stock  
Find more results for VPT
+0.020 (12.50%)
Jun 24 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 0.18 - 0.18
52 week 0.12 - 0.70
Open 0.18
Vol / Avg. 500.00/11,130.00
Mkt cap 4.29M
P/E     -
Div/yield     -
EPS -0.06
Shares 26.80M
Beta -0.26
Inst. own     -


100 W Harrison St Ste 410
SEATTLE, WA 98119-4116
United States - Map
+1-206-2830221 (Phone)
+1-425-7474163 (Fax)

Website links


Ventripoint Diagnostics Ltd. (Diagnostics) is a Canada-based medical device company. The Company develops and commercializes its diagnostic tools to monitor patients with heart disease. By using images produced from existing medical imaging systems, the Ventripoint Medical System (VMS) generates heart volumetric measurements and a three-dimensional (3D) model. Its solution produces critical heart information by processing information received from existing medical imaging equipment with its patented and own methods incorporating Knowledge Based Reconstruction (KBR) algorithms and own cardiac databases. The VMS enables medical professionals to obtain 3D models with critical volume and functional measurements of a patient's heart ventricles. Its KBR method allows for the creation of a 3D model of the right and/or left ventricle using images generated from existing two-dimensional imaging equipment. The Company's technology platform is applicable to a range of heart diseases.

Officers and directors

George Adams President, Chief Executive Officer, Director
Ellen Briant Chief Financial Officer
Alan Rabinowitz Director
Donald H. Segal Ph.D. Director
Age: 68
David A. Willis Director
Danny Dalla-Longa Independent Director